美卫生部长:政府正欲对抗阿片类药物问题

2017-08-10 尹伊雯 环球网

据报道称,美国卫生及公共服务部部长汤姆?普莱斯(Tom Price)在新泽西州的一场新闻发布会中说,总统特朗普认为美国的阿片类药物问题,包括对处方用药的依赖,应按紧急事件处理。

据报道称,美国卫生及公共服务部部长汤姆?普莱斯(Tom Price)在新泽西州的一场新闻发布会中说,总统特朗普认为美国的阿片类药物问题,包括对处方用药的依赖,应按紧急事件处理。

美国疾病防控中心数据显示,2015年包括处方用药和海洛因在内的阿片类药物致美国3.3万人死亡,人数达到史上之最。

据报道,普莱斯8日告诉记者:“总统当然相信我们会将其作为紧急事件处理,而且这确实是紧急事件。”普莱斯还说,尽管白宫正在考虑一切可能的选择以对抗阿片类药物危机,但白宫并不打算在此时宣布该问题为国家紧急事件,原因是这个问题无需宣布就可以解决。

普莱斯还表示,美国卫生及公共服务部正在出台一份综合计划解决这一问题,并将在未来短时间内将该计划提交给特朗普。官方表示,阿片类药物问题依然是美国政府的首要问题之一。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1253036, encodeId=8872125303644, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309059, encodeId=f2f91309059d8, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443324, encodeId=480e1443324b1, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1253036, encodeId=8872125303644, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309059, encodeId=f2f91309059d8, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443324, encodeId=480e1443324b1, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=)]
    2017-08-11 lhlxtx
  3. [GetPortalCommentsPageByObjectIdResponse(id=1253036, encodeId=8872125303644, content=<a href='/topic/show?id=13159e8871d' target=_blank style='color:#2F92EE;'>#阿片类药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97887, encryptionId=13159e8871d, topicName=阿片类药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c83329, createdName=10518093zz, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309059, encodeId=f2f91309059d8, content=<a href='/topic/show?id=a0179e879ac' target=_blank style='color:#2F92EE;'>#阿片类#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97879, encryptionId=a0179e879ac, topicName=阿片类)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7e12358, createdName=lhlxtx, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1443324, encodeId=480e1443324b1, content=<a href='/topic/show?id=d2d0366e60a' target=_blank style='color:#2F92EE;'>#卫生部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36676, encryptionId=d2d0366e60a, topicName=卫生部)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=538e5060306, createdName=12498e67m29暂无昵称, createdTime=Fri Aug 11 23:22:00 CST 2017, time=2017-08-11, status=1, ipAttribution=)]